IDEX Biometrics ASA
IDXAD
$0.001
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -93.89% | -73.68% | -70.05% | -54.55% | 2.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -93.89% | -73.68% | -70.05% | -54.55% | 2.37% |
| Cost of Revenue | -96.18% | -79.65% | -74.04% | 56.08% | -10.50% |
| Gross Profit | -86.18% | -52.20% | -58.97% | -279.26% | 99.08% |
| SG&A Expenses | -48.16% | -36.21% | -28.56% | -46.44% | -29.46% |
| Depreciation & Amortization | -195.88% | 172.95% | 12.35% | 59.49% | 16.52% |
| Other Operating Expenses | -44.51% | -24.33% | -4.14% | -13.05% | 21.59% |
| Total Operating Expenses | -46.74% | -27.98% | -26.77% | -27.72% | -14.72% |
| Operating Income | 40.12% | 18.91% | 19.51% | 23.59% | 16.67% |
| Income Before Tax | 119.33% | 10.79% | 25.07% | 22.29% | 22.04% |
| Income Tax Expenses | -- | 106.67% | -- | 141.67% | -- |
| Earnings from Continuing Operations | 119.35% | 10.40% | 25.12% | 21.60% | 22.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 119.35% | 10.40% | 25.12% | 21.60% | 22.10% |
| EBIT | 40.12% | 18.91% | 19.51% | 23.59% | 16.67% |
| EBITDA | 40.08% | 30.01% | 20.23% | 26.42% | 18.09% |
| EPS Basic | 116.29% | 20.49% | 37.42% | 15.38% | 49.23% |
| Normalized Basic EPS | 93.94% | 20.99% | 37.63% | 15.38% | 49.23% |
| EPS Diluted | 114.33% | 23.67% | 35.48% | 15.38% | 42.31% |
| Normalized Diluted EPS | 93.90% | 20.56% | 38.86% | 16.15% | 49.23% |
| Average Basic Shares Outstanding | 17.54% | 12.81% | 19.76% | -7.66% | 53.57% |
| Average Diluted Shares Outstanding | 17.09% | 12.86% | 22.17% | -7.40% | 53.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
